Ulinastatin

CAS No. 80449-31-6

Ulinastatin ( Bikunin; Mingin; Miraclid; Trypsin inhibitor UTI; Urinary trypsin inhibitor 1; Urinastatin )

Catalog No. M24803 CAS No. 80449-31-6

Ulinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 61 In Stock
25MG 129 In Stock
50MG 205 In Stock
100MG 335 In Stock
200MG 494 In Stock
500MG 782 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ulinastatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Ulinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.
  • Description
    Ulinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.
  • Synonyms
    Bikunin; Mingin; Miraclid; Trypsin inhibitor UTI; Urinary trypsin inhibitor 1; Urinastatin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Kunitz-type serine protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    80449-31-6
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nakahama H , Kuribayashi K , Sugita M , et al. Cytoprotective effect of ulinastatin, a Kunitz-type protease inhibitor, on hypoxic injury in L2 cells treated with antimycin A via stabilization of lysosomal fragility.[J]. Pulmonary Pharmacology & Therapeutics, 1999, 12(1):1-6.
molnova catalog
related products
  • CCTA-1523

    CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.

  • Riligustilide

    Riligustilide is a natural product for research related to life sciences.

  • Cucurbit

    Cucurbit[7]uril is an emerging candidate for pharmaceutical excipients.Cucurbit[7]uril enhances photosensitization of porphyrins in Neuroblastoma cells.